Alternatives
Alternatives to Erzofri extended-release 39 mg/0.25 mL injection
1 other presentations of Paliperidone palmitate 39 mg/0.25 mL injection
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Paliperidone palmitate), strength (39 mg/0.25 mL) and dosage form (injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Erzofri extended-release 39 mg/0.25 mL injectionThis pageIntramuscular | Shandong Luye Pharmaceutical | US FDA | 1 syringe of 0.25 mL | Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F to 86°F). | On request | — | Available on request |
| Invega Sustenna 39 mg/0.25 mL injectionIntramuscular | Janssen Pharmaceuticals | US FDA | 1 syringe of 0.25 mL | Store at room temperature (25 °C, 77 °F), excursions between 15 °C and 30 °C (between 59 °F and 86 °F) are permitted. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Erzofri extended-release 39 mg/0.25 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.